To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C711 in Healthy Adults
NCT06931327 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2025-06-12
Summary
To evaluate the safety and pharmacokinetic characteristics of AJU-C711 in healthy adults
Conditions
Interventions
- DRUG
-
Test Drug
AJU-C711
- DRUG
-
Reference Drug
C711R
Sponsors & Collaborators
-
AJU Pharm Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-03-29
- Primary Completion
- 2025-04-16
- Completion
- 2025-04-18
Countries
- South Korea
Study Locations
More Related Trials
-
A Bioavailability and Pharmacokinetic Study of Subcutaneous and Intravenous RO6811135 in Healthy Volunteers
NCT01802853 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability Study of K0706 in Healthy Subjects
NCT03316820 ·Status: COMPLETED ·Phase: PHASE1
-
To Compare Safety and Pharmacokinetic Properties of CJ-30039 and Lipidil Supra
NCT01501435 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Pharmacokinetic Drug Interactions, Safety and Drug Tolerance in Healthy Volunteers
NCT05463497 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1018-1 and BR1018-2 in Healthy Adult Subjects
NCT05460364 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Multiple Oral Doses of BI 1356 BS on Pharmacokinetics, Safety and Tolerability of Multiple Oral Doses of Simvastatin and on the Pharmacokinetics of Its Metabolite Simvastatin Acid in Healthy Male Volunteers
NCT02183623 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Zilucoplan Injected Subcutaneously Either by a Prefilled Syringe or an Auto-injector in Healthy Adult Participants
NCT06511076 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Bioavailability, Food Effect, Safety and Tolerability of a Solid Dosage Formulation of JNJ-54861911 in Healthy Older Male Participants
NCT02260700 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Safety and PK Characteristics in Healthy Volunteers
NCT06355349 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability Study in Healthy Male Subjects for ZD4054 (Zibotentan) Immediate Release Tablets.
NCT00713791 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Compare Safety and Pharmacokinetics of "CG1801" and "CGL1802" in Healthy Volunteers
NCT03774355 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Amount of Drug Levels in Blood and Safety of AZD5718 Formulations in Healthy Volunteers
NCT04210388 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 639667
NCT02133482 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Bioavailability Study Comparing 3 Different AZD1981 Tablets
NCT01311635 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1018 and Coadministration of BR1018A and BR1018B in Healthy Adult Volunteers
NCT06889012 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics of Single Rising Oral Doses of BI 1181181 in Healthy Male Volunteers, Including Investigation of the Effect of Food on the Bioavailability of BI 1181181
NCT02044406 ·Status: COMPLETED ·Phase: PHASE1
-
AZD9056 Relative Bioavailability Study
NCT00908934 ·Status: COMPLETED ·Phase: PHASE1
-
A Crossover Study to Evaluate Relative Bioavailability of Two JNJ-54781532 Tablet Formulations in Healthy Adult Participants
NCT02117505 ·Status: COMPLETED ·Phase: PHASE1
-
To Investigate the Safety, Tolerability, Pharmacokinetics and the Relative Bioavailability of BI 1026706
NCT01763333 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and PK of UI018
NCT05085184 ·Status: UNKNOWN ·Phase: PHASE1
-
A Single-Center, Open-Label, Randomized, 3-Treatment Crossover Bioavailability Study of Single Oral Doses of E5501 Old Tablet Formulation Under Fasted Conditions and a New Tablet Formulation Under Fed and Fasted Conditions in Healthy Subjects
NCT01260155 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Open-Label Crossover Bioavailability Study of Celecoxib in Healthy Volunteers
NCT00813241 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Pharmacokinetics and Safety of Oral Administration of BR9001 Compared With BR900A in Healthy Subjects
NCT03718611 ·Status: COMPLETED ·Phase: PHASE1
-
An Open-label Single Dose Randomized, Parallel Group Study Followed by Single-blind Repeat Dosing, to Compare the Relative Bioavailability of GSK2212836.
NCT00996268 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of 3 Different Formulations of BI 207127 in Healthy Male Volunteers
NCT01535638 ·Status: COMPLETED ·Phase: PHASE1